Skip to main content
. 2021 Jun 29;22(13):6993. doi: 10.3390/ijms22136993

Table 1.

Correlation of CTC status to clinical parameters of breast cancer, NSCLC and melanoma patients.

Breast Cancer CTC Lung Cancer CTC Melanoma CTC
Negative Positive Negative Positive Negative Positive
Total n 14 7 7 Total n 18 9 9 Total n 11 7 4
% % p % % p % % p
Survival 0.155 Survival 0.501 Survival 0.049
Alive 5 20.0 80.0 Alive 4 50.0 50.0 Alive 6 100.0 0.0
Dead 9 66.7 33.3 Dead 14 57.1 42.9 Dead 5 20.0 80.0
ER 8 37.5 62.5 0.486 BRAF 0 - - - BRAF 8 50.0 50.0 -
PR 6 33.3 66.7 0.486 EGFR 1 0.0 100.0 - PD-L1 3 66.7 33.3 -
HER2 10 40.0 60.0 0.409 NRAS 3 66.7 33.3 -
BRCA1 2 100.0 0.0 -
Metastases Metastases Metastases
Bone 10 0.999 Bone 18 0.999 Bone 6 0.206
No 5 60.0 40.0 No 17 55.6 44.4 No 2 0.0 100.0
Yes 5 40.0 60.0 Yes 1 0.0 100.0 Yes 4 75.0 25.0
Liver 9 0.999 Liver 18 0.999 Liver 8 0.003
No 7 42.9 57.1 No 17 55.6 44.4 No 3 0.0 100.0
Yes 2 50.0 50.0 Yes 1 100.0 0.0 Yes 5 100.0 0.0
Lung 10 0.999 Lung 18 0.999 Lung 8 -
No 5 40.0 60.0 No 17 55.6 44.4 No 0 - -
Yes 5 40.0 60.0 Yes 1 100.0 0.0 Yes 8 50.0 50.0
Lymph node 11 0.437 Lymph node 18 0.999 Lymph node 8 -
No 7 42.9 57.1 No 10 54.5 45.5 No 0
Yes 4 75.0 25.0 Yes 8 62.5 37.5 Yes 8 62.5 37.5
Other organ 9 0.487 Other organ 18 0.999 Other organ 9 0.999
No 5 40.0 60.0 No 15 50.0 50.0 No 1 100.0 0.0
Yes 4 75.0 25.0 Yes 3 100.0 0.0 Yes 8 50.0 50.0
Oligo brain 9 0.999 Oligo brain 18 0.394 Oligo brain 11 0.999
No 7 42.9 57.1 No 3 54.5 45.5 No 10 60.0 40.0
Yes 2 60.0 40.0 Yes 15 47.0 53.0 Yes 1 100.0 0.0